If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chr ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This nine-story project is just ...

Two days to a working application. Three minutes to a live hotfix. Fifty thousand lines of code with comprehensive tests.

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

For the past two years, The Marshall Project has reported on faulty drug testing of patients during childbirth that can lead child welfare agencies to separate newborns from their parents. Our new ...

The productivity app formerly known as Microsoft Project is now part of Microsoft Planner, an app recently redesigned to help anyone who is looking to organize their day, tasks, and projects. It ...

CEOs must put projects, not operations, at the center of how their companies create value. Here’s how. by Antonio Nieto-Rodriguez In an environment of constant change, projects are how businesses ...